ProfileGDS5678 / 1435747_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 56% 55% 55% 55% 55% 58% 57% 55% 57% 55% 55% 55% 56% 55% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.476856
GSM967853U87-EV human glioblastoma xenograft - Control 23.3582755
GSM967854U87-EV human glioblastoma xenograft - Control 33.359455
GSM967855U87-EV human glioblastoma xenograft - Control 43.3231255
GSM967856U87-EV human glioblastoma xenograft - Control 53.3250755
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.5785258
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.5314657
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.3576755
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4602857
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.3519155
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.3679655
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.3527455
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4257656
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.3735655